약학회지 (YAKHAK HOEJI)

  • 제56권5호
  • /
  • Pages.333-345
  • /
  • 2012
  • /
  • 0377-9556(pISSN)
  • /
  • 2383-9457(eISSN)
대한약학회 (The Pharmaceutical Society of Korea)
권호 표지

일반의약품 설명서의 이해도와 적정 사용가능성 평가

Assessment of Readability and Appropriate Usability Based on the Product Labelling of Over-The-Counter Drugs in Korea

  • 투고 : 2012.03.07
  • 심사 : 2012.09.10
  • 발행 : 2012.10.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

Abstract

A product labelling is one of key tools in ensuring that a patient uses drugs safely and effectively in self-care without professional support. This study aimed to explore the readability and comprehensibility of the information contained on two package inserts of medicines. Two package inserts were tested with first year college students. Fifty-one potential consumers underlined words they could not understand and answered 10 scenario questions. Any differences among groups with different characteristics were statistically tested. Secondly, the readability of two package inserts was assessed with comparison to the level of the 6th grade Korean textbooks. As results, more than 80% of participants properly replied to straightforward questions concerning indication, dosage, duplication, use in pregnancy and contraindication, and 73% about formulation. Less than half answered correctly in multiple choice questions about pediatric use (41%) and side effects (35%). Little discrepancy was observed in the comprehensibility between participants' characteristics. Drug inserts contained about 20% more professional-level words than 6th grade textbooks. In conclusion, Korean consumers may face challenges to understand drug information due to professional terminology and outdated expressions in the current package inserts. To secure safe and effective use of over-the-counter agents, greater efforts should be made to develop more consumer friendly labels. In the other hand, educational supports are required to prepare consumers in a proper level of knowledge for the safe use of drugs.

Keywords

References

  1. 보건복지부. 약사법. 서울 : 보건복지부 (2012).
  2. Pawaskar, M. D. and Balkrishnan, R. : Switching from prescription to over-the counter medications: a consumer and managed care perspective. Managed Care Interface 20, 42 (2007).
  3. Carlsten, A., Wennberg, M. and Bergendal, L. : The influence of Rx-to-OTC changes on drug sales. Experiences from Sweden 1980-1994. J. Clin. Pharm. Ther. 21, 423 (1996).
  4. Kunz, K., Arundell, E. and Cisternas, M. : Economic implications of self-treatment of heartburn/nonulcer dyspepsia with nonprescription famotidine in a managed care setting. Journal of Managed Care Pharmacy 2, 263 (1996).
  5. Bradley, C. P. and Bond, C. : Increasing the number of drugs available over the counter: arguments for and against. British Journal of General Practice. 45, 553 (1995).
  6. Erwin, J., Britten, N. and Jones, R. : General practitioners' views on the over-the-counter availability of H2-antagonists. British Journal of General Practice. 47, 99 (1997).
  7. 리병도, 변혜진, 우석균 : '일반의약품 수퍼판매' 논란, 어떻게 바라보아야 할 것인가? 서울 : 건강과 대안 (2011).
  8. Gianfrancesco, F., Manning, B. and Wang, R. : Effects of prescription to OTC Switches on out-of-pocket health care costs and utilization. Drug Benefit Trends. 14, 13-30, 44 (2002).
  9. Lynd, L. D., Taylor, J., Dobson, R. and Willison, D. J. : Prescription to over-the-counter deregulation in Canada: are we ready for it, or do we need to be? CMAJ 173, 775 (2005).
  10. Bradley, C. and Blenkinsopp, A. : The future for self medication. BMJ 312, 835 (1996).
  11. Holt, G. A., Hollon, J. D., Hughes, S. E. and Coyle, R. : OTC labels: can consumers read and understand them? American Pharmacy NS30, 51 (1990).
  12. Roumie, C. L. and Griffin, M. R. : Over-the-counter analgesics in older adults: a call for improved labelling and consumer education. Drugs and Aging. 21, 485 (2004).
  13. Weiss, B. D., Coyne, C., Michielutte, R., Davis, T. C., Meade, C. D., Doak, L. G., Cecilia, C. D., Brown, P., Askov, E., Mettger, W., Songer, T., Friedell, G. H. and Smith, T. : Communicating with patients who have limited literacy skills: Report of the National Work Group on Literacy and Health. Journal of Family Practice. 46, 168 (1998).
  14. Coulter, A., Parsons, S. and Askham, J. : Where are the patients in decision-making about their own care?, WHO European Ministerial Conference on Health Systems. Tallinn, Estonia (2008).
  15. Haynes, R. B., Ackloo, E., Sahota, N., McDonald, H. P. and Yao, X. : Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews. DOI: 10.1002/ 14651858.CD000011.pub3 (2008).
  16. U.S. Department of Health and Human Services, O. o. D. P. a. H. P. National action plan to improve health literacy. Washington, DC: Author (2010).
  17. 용철순, 이숙향, 권경희 : 의약품의 분류번호 및 관리제도 개선 연구. 식품의약품안전청 (2010).
  18. 윤주애 : 소비자 알권리 위해 의약품 표시사항 정비. 메디칼투데이 (2009).
  19. 한국소비자원 : 국내외 일반의약품 표시 실태조사 보고서. 서울: 소비자안전센터, 소비자안전본부 식의약안전팀 (2008).
  20. 송유진, 유현정 : 한중미일 일반의약품의 표시기준과 내용분석. 한국위기관리논집 6, 139 (2010).
  21. 김경아 : 환자용 설명서와 전문가용 설명서에 대한 이해도 비교 분석. 임상약학대학원. 서울: 숙명여자대학교 (2007).
  22. 남수정, 유현정 : 의약품 표시와 소비자능력. 소비문화연구 13, 21 (2010).
  23. 한형선 : 자가투약 환자의 의약품 정보원 이용실태 분석. 의약식 품대학원. 서울: 중앙대학교 (2000).
  24. Sheen, C. L., Dillon, J. F., Bateman, D. N., Simpson, K. J. and Macdonald, T. M. : Paracetamol toxicity: epidemiology, prevention and costs to the health-care system. QJM 95, 609 (2002).
  25. Health Literacy Innovations. National survey of Medicaid guidelines for heatlh literacy. Health Literacy Innovations (2007).
  26. 최숙기 : 공통핵심교육과정(CCSS)의 읽기 텍스트 위계화 방안에 관한 연구. 교육과정평가연구 14, 1 (2011).
  27. 이성영 : 초등 교과서의 이독성 비교 연구: 국어, 사회, 과학 교 과서를 중심으로. 국어교육학연구 41, 169 (2011).
  28. 강석진, 박수연 : 과학 교과서와 사회 교과서의 이독성 비교. Journal of the Society for the International Gifted in Science 3, 55 (2009).
  29. 김광해 : 등급별 국어교육용 어휘. 박이정. 서울 (2003).
  30. Emmerton, L. M., Mampallil, L., Kairuz, T., McKauge, L. M. and Bush, R. A. : Exploring health literacy competencies in community pharmacy. Health Expectations 15, 12 (2012).
  31. Raynor, D. K., Silcock, J., Knapp, P. and Edmondson, H. : How do patients use medicine information leaflets in the UK? International Journal of Pharmacy Practice. 15, 209 (2007).
  32. Raynor, D. K. T. : Testing, testing. User testing and how it will revolutionise how we think about patient information leaflets. Leeds (2005).
  33. Gunn, V. L., Taha, S. H., Liebelt, E. L. and Serwint, J. R. : Toxicity of over-the-counter cough and cold medications. Pediatrics. 108, E52 (2001).
  34. Ryan, T., Brewer, M. and Small, L. : Over-the-counter cough and cold medication use in young children. Pediatric Nursing. 34, 174 (2008).
  35. 박실비아, 박은자, 채수미. 의약품 첨부문서의 국가별 비교분석. 보건복지포럼 2010-2, 40-55 (2010).
  36. Kraushaar, K. J. : Market exclusivity after a prescription to nonprescription drug switch: striking the right balance between innovation and competition. Food and Drug Law Journal 54, 243 (1999).
  37. Brass, E. P. : Implications of a switch from prescription to overthe- counter status for allergy drugs. Current Allergy and Asthma Reports. 4, 245 (2004).
  38. Morgan, P. P. and Cohen, L. : Off the prescription pad and over the counter: the trend toward drug deregulation grows. CMAJ: Canadian Medical Association journal=Journal de l'Association Medicale Canadienne. 152, 387 (1995).
  39. 이유정 : 지역약국 방문 성인 환자의 acetaminophen 사용 현황 평가. 약학회지 54, 174 (2010).